c smith

Healthcare Profits: Assessing Company Sensitivity to Obamacare

A better measure of sensitivity to ObamaCare is percentage of revenue which is "private pay"; i.e.; that which is not publicly funded via Medicare or Medicaid. Allergan, which derives the great majority of its revenue from elective and cosmetic procedures (which are not paid for w/public dollars) is the hands-down winner by this measure.